Fuso Pharmaceutical Industries, Ltd.

Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.

Latest values as text and table

Fuso Pharmaceutical Industries, Ltd.

Fuso Pharmaceutical Industries, Ltd. (扶桑薬品工業株式会社, 4538), Pharmaceutical. 15 cross-shareholdings, a board of 11 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YHSC, filed 2026-06-23. Source: company filings on EDINET (Financial Services Agency of Japan).

Financial summary

Five-year summary as filed, latest filing per fiscal year
Fiscal year endRevenue (¥bn)Profit (¥bn)Total assets (¥bn)EPS (¥)DPS (¥)Employees
2022-03-3149.61.569.3169.0960.001,344
2023-03-3151.01.672.5183.0770.001,314
2024-03-3155.41.475.8159.9870.001,307
2025-03-3160.6−3.381.7−384.9582.001,340
2026-03-3162.32.090.3235.6390.001,374

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON

Cross-shareholdings

Ten largest cross-shareholdings by book value, latest annual report
Company heldSharesBook value (¥bn)% of shares outstanding
Mitsubishi UFJ Financial Group, Inc.434,2001.10.0
Sumitomo Mitsui Financial Group, Inc.216,0001.10.0
Sumitomo Mitsui Trust Group, Inc.162,5720.80.0
TOHO HOLDINGS CO.,LTD.94,0000.40.1
Nippon Fine Chemical Co., Ltd.172,7000.40.8
Alfresa Holdings Corporation143,2080.40.1
3-D Matrix,Ltd.640,0000.30.5
Hokuhoku Financial Group, Inc.35,4000.20.0
Resona Holdings, Inc.53,8000.10.0
Daito Pharmaceutical Co.,Ltd.48,4000.10.2

% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown